Lataa...
Adoptive cell therapy using PD-1(+) myeloma-reactive T cells eliminates established myeloma in mice
BACKGROUND: Adoptive cellular therapy (ACT) with cancer antigen-reactive T cells following lymphodepletive pre-conditioning has emerged as a potentially curative therapy for patients with advanced cancers. However, identification and enrichment of appropriate T cell subsets for cancer eradication re...
Tallennettuna:
| Julkaisussa: | J Immunother Cancer |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5477110/ https://ncbi.nlm.nih.gov/pubmed/28642819 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-017-0256-z |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|